Autosomal dominant tubulointerstitial kidney disease in Chinese patients
Mengshi Li(King University), Shu‐Feng Zhou(RMIT University), Lei Jiang(China Pharmaceutical University), Zhuo-ran Song(King University), Jicheng Lv(Ministry of Education of the People's Republic of China), Bin Wang(Zhongda Hospital Southeast University), Hong Zhang(University of Hawaiʻi at Mānoa), Yuqing Chen(Shanghai Chest Hospital), Li Yang(Peking University), Rui You(Peking University), Zhiying Liu(Tianjin University), X Wang(Peking University)
Cited by 0
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
|Kidney International|2017|1.2k